自我穴位按压治疗季节性过敏性鼻炎的随机对照探索性试验
该随机对照探索性试验比较了自我穴位按压加按需西替利嗪与单用按需西替利嗪对季节性过敏性鼻炎患者的疗效。
要点
- 自我穴位按压可改善季节性过敏性鼻炎患者的生活质量。
- 穴位按压可减轻总体症状并可能减少抗过敏药物使用。
- 结果需高质量假对照验证性研究进一步确认。
核心结论
- 自我穴位按压可行,可能改善疾病特异性生活质量、减轻症状并减少抗过敏药物摄入。
研究设计与样本
- 两臂随机对照探索性试验,比较4周自我穴位按压(五个穴位)加按需西替利嗪与单用按需西替利嗪。
主要发现
- 4周后组间调整均值差:鼻结膜炎生活质量问卷-0.9分(95% CI -1.6至-0.2;p=0.011)。
- 4周后组间调整均值差:总体症状视觉模拟评分-21.6 mm(95% CI -36.3至-6.8;p=0.005)。
- 按需药物评分组间差1.9分(95% CI -3.8至-0.1;p=0.120)。
- 组间差异至第8周略有减小,穴位按压可行且安全。
临床怎么用
- 可考虑将自我穴位按压作为季节性过敏性鼻炎患者的辅助自我护理技术。
- 需告知患者当前证据来自探索性试验,确证性研究尚未完成。
局限性
- 探索性试验样本量小,缺乏假穴位按压对照组。
- 结果需高质量确证性研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Acupuncture has shown beneficial effects for seasonal allergic rhinitis (SAR); however, it is time and cost intensive. We investigated feasibility and effects of self-administered body acupressure as a self-care technique that stimulates acupuncture points with manual pressure in SAR patients. METHODS: We conducted a two-armed randomized controlled exploratory trial to compare effects of self-administered acupressure over 4 weeks at five acupuncture points plus rescue medication (RM) with cetirizine compared to RM alone in SAR patients. Among other outcome parameters, we assessed disease-related quality of life (Rhinitis Quality of Life Questionnaire [RQLQ]), overall SAR symptoms by a visual analogue scale (VAS) and a rescue medication score (RMS) after 4 and 8 weeks. RESULTS: Forty-one SAR patients (mean age 38.5 ± 10.0 years, n = 21, 51.2% women) were randomized. Compared to RM alone (n = 21), acupressure plus RM (n = 20) was associated with relevant improvements after 4 weeks, shown by the difference between groups in adjusted means of RQLQ: - 0.9 points (95% CI - 1.6 to - 0.2; p = 0.011) and VAS overall SAR symptoms: - 21.6 mm (95% CI - 36.3 to - 6.8; p = 0.005). The RMS was lower in the acupressure group than in the control group: 1.9 points (95% CI - 3.8 to - 0.1; p = 0.120). Group differences decreased slightly until week 8. The acupressure was feasible and safe. CONCLUSION: Results of this exploratory study indicate that self-applied acupressure is feasible, may improve disease-specific quality of life and reduce disease-related symptoms as well as anti-allergic medication intake in SAR patients. High-quality confirmatory studies including a sham-control group are needed in the future. Trial registration DRKS-ID: DRKS00014310. Date of registration in DRKS: 2018/04/24. Investigator sponsored/initiated trial (IST/IIT): yes. Ethics approval/approval of the ethics committee: Approved (leading) Ethics Committee No. EA1/033/18, Ethik-Kommission der Charité -Universitätsmedizin Berlin. URL: https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00014310.
引用
- Israel L, Rotter G, Förster-Ruhrmann U, et al. Acupressure in patients with seasonal allergic rhinitis: a randomized controlled exploratory trial. Chin Med. 2021. PMID: 34922567. doi:10.1186/s13020-021-00536-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。